Erythropoietin analogs

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/18 (2006.01) A61K 38/18 (2006.01) A61K 38/24 (2006.01) C07K 14/505 (2006.01) C07K 14/59 (2006.01) C07K 19/00 (2006.01) C12N 5/10 (2006.01) C12N 15/62 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2147124

Erythropoietin analogs having at least one additional site for glycosylation, or a rearrangement of at least one site for glycosylation are disclosed. The invention also relates to DNA sequences encoding said erythropoietin analogs, and recombinant plasmids and host cells for analog expression.

L'invention concerne des analogues d'érythropoïétine possédant au moins un site additionnel de glycosylation ou une redisposition d'au moins un site de glycosylation. Elle concerne également des séquences d'ADN codant lesdits analogues d'érythropoïétine, ainsi que des plasmides recombinés et des cellules hôtes d'expression d'analogues.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Erythropoietin analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythropoietin analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythropoietin analogs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1661266

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.